Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

Pulmonx (LUNG) Shares Repurchased (2020 - 2022)

Pulmonx has reported Shares Repurchased over the past 3 years, most recently at $27000.0 for Q4 2022.

Quarterly Shares Repurchased changed N/A to $27000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $27000.0 through Dec 2022, up 3.85% year-over-year, with the annual reading at $27000.0 for FY2022, 3.85% up from the prior year.
Shares Repurchased was $27000.0 for Q4 2022 at Pulmonx, up from $26000.0 in the prior quarter.
Over five years, Shares Repurchased peaked at $27000.0 in Q4 2022 and troughed at $21000.0 in Q3 2020.
The 3-year median for Shares Repurchased is $26000.0 (2021), against an average of $24666.7.